Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

115
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
115
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

166
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
166
Actuarial Approach01:20

Actuarial Approach

69
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
69
Censoring Survival Data01:09

Censoring Survival Data

73
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
73
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

35
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
35

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A more interpretable regression model for count data with excess of zeros.

Statistical methods in medical research·2026
Same author

Artificial intelligence-enabled plaque characterization from coronary computed tomography establishes basis of angina in women with nonobstructive atherosclerosis.

Communications medicine·2026
Same author

Paramagnetic Rim Lesions Are Associated With Trans-Synaptic Degeneration of the Visual Pathway in Multiple Sclerosis.

Annals of clinical and translational neurology·2026
Same author

Modified Skew Discrete Laplace Regression Models for Integer-Valued Data With Applications to Paired Samples.

Biometrical journal. Biometrische Zeitschrift·2025
Same author

The multivariate shared truncated normal frailty model with application to medical data.

Scientific reports·2025
Same author

A new proportional hazard model with applications to breastfeeding data.

Scientific reports·2025

相关实验视频

Updated: Jun 17, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

一个新的混合模型与治愈率应用于乳腺癌数据.

Diego I Gallardo1, Márcia Brandão2, Jeremias Leão2

  • 1Departamento de Estadística, Facultad de Ciencias, Universidad del Bío-Bío, Concepción, Chile.

Biometrical journal. Biometrische Zeitschrift
|August 6, 2024
PubMed
概括

我们开发了一种新的长期生存模型,使用Poisson和Birnbaum-Saunders分布混合用于竞争风险. 这种灵活的模型准确地估计了治愈率,并且在乳腺癌发病率数据中优于传统方法.

关键词:
伯恩姆·桑德斯·桑德斯 在乳腺癌数据 乳腺癌数据导致相互竞争的原因.治愈率模型 治愈率模型预期最大化算法

更多相关视频

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

239
Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
08:08

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

Published on: June 11, 2014

15.8K

相关实验视频

Last Updated: Jun 17, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

239
Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
08:08

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

Published on: June 11, 2014

15.8K

科学领域:

  • 生物统计学 生物统计学
  • 生存分析的分析.
  • 统计建模 统计建模

背景情况:

  • 传统的生存模式往往在复杂的场景中扎,其中涉及多种相互竞争的失败原因.
  • 建模治愈率,即代表不太可能经历某一事件的个体,在长期研究中至关重要.
  • 现有的方法可能无法充分捕捉竞争风险的细微差别和对治愈率的共变效应.

研究的目的:

  • 引入一种新的灵活的长期生存模型,用于分析具有竞争风险的数据.
  • 调查拟议模型的统计性质和理论基础.
  • 证明模型能够直接结合共变量来建模治愈率的能力.

主要方法:

  • 提出了一个新的生存模型,假设相互竞争的原因遵循Poisson和Birnbaum-Saunders分布的混合.
  • 统计学属性,包括促销时间模型作为局限性情况的出现,是衍生出来的.
  • 开发了一个预期最大化 (EM) 算法,用于使用最大概率 (ML) 进行参数估计.
  • 蒙特卡洛模拟用于评估概率比率 (LR) 测试的估计性能和功率.
  • 该模型应用于现实世界乳腺癌发病率数据集.

主要成果:

  • 拟议的模型允许直接建模治愈率作为共变量的函数.
  • 建立了足够的条件,以确保ML估计器的一致性和异常正常性.
  • 与推广时间模型相比,模拟研究证实了模型的性能和LR测试的功率.
  • 对乳腺癌数据的应用表明,与传统方法相比,模型适合性优越.

结论:

  • 新的生存模型提供了一个灵活而强大的工具,用于分析具有竞争风险的长期生存数据.
  • 该模型有效地结合了共变量来估计治愈率,提供了有价值的见解.
  • 拟议的方法证明了其实用性和在流行病学和临床研究中改善分析的潜力.